1
Study Evaluating Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma
Condition(s):Head-and-neck Squamous Cell CarcinomaLast Updated:June 21, 2022Not yet recruiting
Head and Neck Squamous Cell Carcinoma: 2262 Clinical Trials, Page 1 of 227
Hide Studies Not Open or Pending
2
A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Condition(s):Head and Neck Squamous Cell Carcinoma (HNSCC)Last Updated:February 11, 2022Active, not recruiting
3
Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial
Condition(s):Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) HNSCCLast Updated:February 17, 2023Active, not recruiting
4
Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition(s):Locally Advanced Head and Neck Squamous Cell CarcinomaLast Updated:March 22, 2023Not yet recruiting
5
Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition(s):Head and Neck Squamous Cell Carcinoma; Neoadjuvant ChemotherapyLast Updated:August 31, 2022Recruiting
6
CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:November 16, 2022Active, not recruiting
7
(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
Condition(s):Head and Neck Squamous Cell Carcinoma; Metastatic Head and Neck Squamous Cell Carcinoma; Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Last Updated:February 28, 2023Not yet recruiting
8
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)-China Extension Study
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:February 28, 2023Recruiting
9
BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:March 28, 2022Not yet recruiting
10
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)
Condition(s):Head and Neck Squamous Cell CarcinomasLast Updated:November 1, 2022Recruiting